REQUEST A DEMO
Total
USD $0.00
Search more companies

Bhushan Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Bhushan Pharmaceuticals Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Bhushan Pharmaceuticals Private Limited is based in India. The head office is in Delhi. The company operates in the Pharmaceutical and Medicine Manufacturing sector. It was incorporated on April 12, 1991. In 2024, the company reported a net sales revenue increase of 17.34%. Its’ total assets recorded a growth of 20.99%. The enterprise’s net profit margin increased by 0.94% in 2024.

Legal Address
39/23 Gali No.15 Samaipurdelhi
Delhi; Delhi; Postal Code: 000000

Contact Details: Purchase the Bhushan Pharmaceuticals Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Bhushan Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Bhushan Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
April 12, 1991
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Bhushan Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
17.34%
Total Operating Revenue
17.27%
Operating Profit
132.64%
EBITDA
104.34%
Net Profit/Loss for the Period
122.49%
Total Assets
20.99%
Total Equity
5.5%
Operating Profit Margin
1.41%
Net Profit Margin
0.94%
Return on Equity (ROE)
12.23%
Debt / Equity
72.21%
Quick Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?